Bradley Canino
Stock Analyst at Stifel
(1.93)
# 3,092
Out of 4,947 analysts
85
Total ratings
31.58%
Success rate
-4.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $2.79 | +437.63% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $0.66 | +129.01% | 8 | Mar 7, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $23 → $19 | $7.60 | +150.16% | 2 | Feb 28, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $3.39 | +578.47% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $7.08 | +620.34% | 6 | Feb 12, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $115 | $24.98 | +360.37% | 2 | Dec 3, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $40 → $41 | $14.73 | +178.34% | 5 | Oct 14, 2024 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $6.60 | +187.88% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $51.89 | -19.06% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $26.45 | +51.23% | 4 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $76.80 | +75.78% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $9.93 | +101.41% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.13 | +784.96% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $1.48 | +575.68% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $99 | $66.94 | +47.89% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $2.35 | +495.74% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $41.55 | +32.37% | 4 | Feb 23, 2024 |
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $2.79
Upside: +437.63%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $0.66
Upside: +129.01%
Cullinan Therapeutics
Feb 28, 2025
Maintains: Buy
Price Target: $23 → $19
Current: $7.60
Upside: +150.16%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $3.39
Upside: +578.47%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $7.08
Upside: +620.34%
Janux Therapeutics
Dec 3, 2024
Maintains: Buy
Price Target: $70 → $115
Current: $24.98
Upside: +360.37%
Syndax Pharmaceuticals
Oct 14, 2024
Maintains: Buy
Price Target: $40 → $41
Current: $14.73
Upside: +178.34%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $6.60
Upside: +187.88%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $51.89
Upside: -19.06%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $26.45
Upside: +51.23%
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $76.80
Upside: +75.78%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $9.93
Upside: +101.41%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.13
Upside: +784.96%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $1.48
Upside: +575.68%
Jun 17, 2024
Maintains: Buy
Price Target: $90 → $99
Current: $66.94
Upside: +47.89%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $2.35
Upside: +495.74%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $41.55
Upside: +32.37%